ARTICLE | Company News
EdiGene, Genetron collaborate to identify cancer targets
April 5, 2019 4:40 PM UTC
Gene editing company EdiGene and precision medicine play Genetron partnered to identify targets for therapeutics and companion diagnostics in cancer.
EdiGene Inc. (Beijing, China) will use its high-throughput genomic screening platform to identify targets and validate them in a tumor database from Genetron Health Co. Ltd. (Beijing, China). EdiGene said the database covers all cancers of high frequency in China...